Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 131631 - 131640 of 132111 results

First page
Previous page
Next page
Next page

MICROCRYSTALLINE CELLULOSE 101

7T9FYH5QMK

Status:

Possibly Marketed Outside US

Source:

21 CFR 341

(2018)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53a66dc7-2448-4796-bd66-fbfc1e9d693f

First approved in 1953

Source:

ANDA081235

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b54b5c4-2466-4f85-b9a0-ad93ec4a06a1

Class:

G1 SPECIFIED SUBSTANCE

ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 40% AQUEOUS)

0MKJ04EU89

Status:

Possibly Marketed Outside US

Source:

NDA209777

(1950)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=72398542-8e0a-47b2-afeb-9ca5a1f15083

First approved in 1950

Source:

NDA209777

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=72398542-8e0a-47b2-afeb-9ca5a1f15083

Class:

G1 SPECIFIED SUBSTANCE

ACP-001

5377795HRF

Status:

US Approved Rx (1995)

Source:

BLA020280

(1995)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020280

First approved in 1976

Source:

Asellacrin by Hoechst Roussel

Source URL:

OB NME Appendix 1950-1985

Class:

CONCEPT

PROTAMINE

72G3UY6T4N

Status:

US Approved Rx (1987)

Source:

ANDA089454

(1987)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=089454

First approved in 1950

Source:

PROTAMINE SULFATE by LILLY

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006460

Class:

CONCEPT

AMG-172

B6M586T6SD

Status:

Investigational

Source:

NCT01497821: Phase 1 Interventional Completed Renal Cell Adenocarcinoma

(2012)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01497821

Class:

CONCEPT

DV-281

4LOR72V17G

Status:

Investigational

Source:

NCT03326752: Phase 1 Interventional Completed Advanced Non Small Cell Lung Cancer

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03326752

Class:

CONCEPT

47D11

20YWF2NH7O

Status:

Investigational

Source:

INN:12070

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/20YWF2NH7O

Class:

CONCEPT

ROSE-010

P94L7H3TDK

Status:

Investigational

Source:

NCT01056107: Phase 1/Phase 2 Interventional Completed Irritable Bowel Syndrome Constipation Predominant

(2010)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01056107

Class:

CONCEPT

SAB-185

GZH7FFK82R

Status:

Investigational

Source:

NCT04468958: Phase 1 Interventional Completed COVID-19

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04468958

Class:

CONCEPT

IGM-8444

4JZ0485VXV

Status:

Investigational

Source:

NCT04553692: Phase 1 Interventional Recruiting Solid Tumor

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04553692

Class:

CONCEPT

Concept

MICROCRYSTALLINE CELLULOSE 101

Concept

ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 40% AQUEOUS)

Concept

ACP-001

Concept

PROTAMINE

Concept

AMG-172

Concept

DV-281

Concept

47D11

Concept

ROSE-010

Concept

SAB-185

Concept

IGM-8444

Showing 131631 - 131640 of 132111 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1